Simpson Curran 4
4 · REGENXBIO Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Simpson Curran
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-01-02+98,912→ 257,032 total - Award
Stock Options (Right to buy)
2025-01-02+476,606→ 476,606 totalExercise: $7.86Exp: 2035-01-02→ Common Stock (476,606 underlying) - Tax Payment
Common Stock
2025-01-02$7.73/sh−11,917$92,118→ 158,120 total
Footnotes (3)
- [F1]Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024.
- [F2]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer.
- [F3]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.